Watchlist Price Alert

Skye Bioscience Inc. (SKYE)

NASDAQ: SKYE · Real-Time Price · USD

2.07

-0.05 (-2.36%)

At close: Jun 17, 2025, 3:59 PM

2.02

-2.37%

After-hours: Jun 17, 2025, 07:20 PM EDT

Skye Bioscience Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	68.42M	1.26M	1.24M	8.98M	2.47M	1.83M	1.85M	259.95K	64.82K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	53.91K	8.31K	8.31K	8.31K	n/a	n/a	n/a	n/a	34.29K
Receivables	5.07K	158.24K	74.12K	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.41M	9.64M	6.74M	61.44K	4.84K	12.09K	7.12K	4.43K	44.51K
Total Current Assets	70.83M	11.65M	8.94M	9.61M	2.66M	1.99M	1.95M	555.81K	279.49K
Property-Plant & Equipment	1.88M	281.26K	159.04K	234.68K	7.34K	1.98K	3.44K	1.41K	9.58K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.94M	289.57K	167.35K	242.99K	7.34K	1.98K	3.44K	1.41K	43.87K
Total Assets	72.76M	11.94M	9.11M	9.86M	2.67M	2M	1.96M	557.22K	323.36K
Account Payables	569.25K	1.16M	1.79M	900.01K	381.37K	139.81K	15.6K	100.92K	274.65K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	182.43K	4.37M	1.9M	1.97M	64.06K	n/a	n/a	235K	n/a
Other Current Liabilities	3.77M	7.03M	7.48M	435.57K	38.57K	410.6K	15.74M	271.71K	121.27K
Total Current Liabilities	4.34M	13.9M	12.12M	3.91M	787.2K	970.82K	15.94M	805.97K	661.96K
Long-Term Debt	273.16K	n/a	n/a	n/a	1.43M	387.07K	1.36M	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	90.8K	219.45K	551.32K	1.11M
Total Long-Term Liabilities	273.16K	171.23K	n/a	78.7K	1.43M	477.87K	1.58M	551.32K	1.11M
Total Liabilities	4.61M	14.07M	12.12M	3.99M	2.22M	1.45M	17.52M	1.36M	1.77M
Total Debt	455.59K	4.62M	1.98M	2.14M	1.5M	387.07K	1.36M	235K	n/a
Common Stock	30.98K	12.35K	3.65K	476.11K	288.07K	182.9K	133.91K	33.62K	21.56K
Retained Earnings	-130.95M	-104.38M	-66.74M	-47.26M	-38.73M	-32.17M	-33.23M	-14.03M	-10.94M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	68.15M	-2.13M	-3.01M	5.86M	450.79K	548.06K	-15.56M	-800.08K	-1.45M
Total Investments	n/a	-9.08M	n/a	n/a	n/a	n/a	n/a	n/a	n/a